NCT06944119View on ClinicalTrials.gov

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

Active, not recruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

March 31, 2027

Conditions

MyelomaLymphomaCLLMyelodysplastic SyndromeLeukemia Acute Myeloid - AML

Trial Locations (1)

Unknown

Tel Aviv Sourasky Medical Center, Tel Aviv

All Listed Sponsors

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV